Published in EMBO J on May 01, 1995
Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol Cell Biol (1996) 3.50
Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc Natl Acad Sci U S A (1999) 3.46
Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A (1998) 3.27
Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev (1998) 3.01
The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol (1996) 2.47
BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci U S A (2000) 1.85
Mechanism of repression of RNA polymerase I transcription by the retinoblastoma protein. Mol Cell Biol (1997) 1.82
The J domain of simian virus 40 large T antigen is required to functionally inactivate RB family proteins. Mol Cell Biol (1998) 1.70
Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol (1996) 1.66
The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J Virol (1996) 1.63
BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. Mol Cell Biol (2004) 1.57
Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells. Mol Cell Biol (1998) 1.52
Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proc Natl Acad Sci U S A (1996) 1.51
p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol Cell Biol (1998) 1.39
p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol Cell Biol (1997) 1.37
The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J Virol (1996) 1.33
p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol Cell Biol (1997) 1.31
Modulation of cell proliferation by cytokeratins K10 and K16. Mol Cell Biol (1999) 1.30
Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4. Mol Cell Biol (2002) 1.26
Transcriptional repression and growth suppression by the p107 pocket protein. Mol Cell Biol (1996) 1.18
p21 Disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol (1996) 1.16
Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Mol Cell Biol (1998) 1.14
Mitogenic Sonic hedgehog signaling drives E2F1-dependent lipogenesis in progenitor cells and medulloblastoma. Oncogene (2010) 1.09
p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. J Cell Biol (2005) 1.03
Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div (2009) 1.02
The retinoblastoma family: twins or distant cousins? Genome Biol (2002) 1.02
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107. Proc Natl Acad Sci U S A (2003) 0.98
The Rb family contains a conserved cyclin-dependent-kinase-regulated transcriptional repressor motif. Mol Cell Biol (1996) 0.97
Interactions between human cytomegalovirus IE1-72 and cellular p107: functional domains and mechanisms of up-regulation of cyclin E/cdk2 kinase activity. J Virol (2003) 0.96
p107 in the public eye: an Rb understudy and more. Cell Div (2010) 0.94
Genomic structure of the human retinoblastoma-related Rb2/p130 gene. Proc Natl Acad Sci U S A (1996) 0.92
Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle. J Cell Biol (2000) 0.88
Biochemical characterization of Cdk2-Speedy/Ringo A2. BMC Biochem (2005) 0.87
Pocket protein p130/Rb2 is required for efficient herpes simplex virus type 1 gene expression and viral replication. J Virol (2001) 0.82
Differential control of transcription by DNA-bound cyclins. Mol Biol Cell (2001) 0.82
Pocket proteins critically regulate cell cycle exit of the trabecular myocardium and the ventricular conduction system. Biol Open (2013) 0.77
Novel functions for the transcription factor E2F4 in development and disease. Cell Cycle (2016) 0.76
The Evolutionarily Conserved C-terminal Domains in the Mammalian Retinoblastoma Tumor Suppressor Family Serve as Dual Regulators of Protein Stability and Transcriptional Potency. J Biol Chem (2015) 0.76
Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation. Oncotarget (2016) 0.75
Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins. J Biol Chem (2017) 0.75
E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (1992) 10.28
The E2F transcription factor is a cellular target for the RB protein. Cell (1991) 9.62
Distinct roles for cyclin-dependent kinases in cell cycle control. Science (1993) 8.13
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol (1994) 7.40
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell (1993) 7.19
Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell (1991) 5.98
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev (1992) 5.73
Tumor suppressor genes. Science (1991) 5.72
Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J Virol (1985) 5.69
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54
Retinoblastoma protein switches the E2F site from positive to negative element. Nature (1992) 5.47
Physical interaction of the retinoblastoma protein with human D cyclins. Cell (1993) 5.31
The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell (1992) 5.05
Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev (1994) 4.93
Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science (1993) 4.81
The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell (1991) 4.69
Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14
Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell (1994) 4.01
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96
The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75
A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell (1992) 3.64
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54
An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J (1993) 3.48
Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell (1991) 3.47
Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev (1994) 3.47
Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev (1993) 3.41
Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev (1994) 3.27
The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev (1993) 3.10
Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science (1994) 3.05
E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev (1994) 3.05
A link between cyclin A expression and adhesion-dependent cell cycle progression. Science (1993) 2.96
E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev (1994) 2.86
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol (1992) 2.78
Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J (1993) 2.70
Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science (1993) 2.70
RNA polymerase II transcription blocked by Escherichia coli lac repressor. Science (1990) 2.65
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1993) 2.61
Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J (1993) 2.55
Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A (1993) 2.55
A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci U S A (1990) 2.46
The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol (1993) 2.41
Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (1992) 2.39
Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J (1994) 2.14
Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13
Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol (1992) 2.13
Transcriptional repression by the Rb-related protein p107. Mol Biol Cell (1993) 1.72
Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst (2000) 16.92
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
Creation of human tumour cells with defined genetic elements. Nature (1999) 16.47
Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell (1997) 8.74
Distinct roles for cyclin-dependent kinases in cell cycle control. Science (1993) 8.13
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69
Cellular targets for transformation by the adenovirus E1A proteins. Cell (1989) 7.53
New functional activities for the p21 family of CDK inhibitors. Genes Dev (1997) 6.97
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell (1989) 6.68
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell (1992) 6.32
Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J Virol (1985) 5.69
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54
Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature (1983) 5.40
Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol (1994) 5.18
rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science (1996) 5.13
A family of human cdc2-related protein kinases. EMBO J (1992) 4.96
Inhibition of telomerase limits the growth of human cancer cells. Nat Med (1999) 4.96
Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol (1980) 4.88
Tumor induction and tissue atrophy in mice lacking E2F-1. Cell (1996) 4.80
Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc Natl Acad Sci U S A (1996) 4.70
Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J (1992) 4.69
Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature (1991) 4.36
Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21
The 2.2 kb E1b mRNA of human Ad12 and Ad5 codes for two tumor antigens starting at different AUG triplets. Cell (1981) 4.16
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14
Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol (1986) 4.14
Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci U S A (1998) 4.11
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature (1994) 3.95
CDK-independent activation of estrogen receptor by cyclin D1. Cell (1997) 3.85
The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75
Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev (1996) 3.61
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54
Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev (1994) 3.47
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (1995) 3.41
E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol (1996) 3.40
Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell (1990) 3.37
Point mutational inactivation of the retinoblastoma antioncogene. Science (1989) 3.37
Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A (1998) 3.27
E2f3 is critical for normal cellular proliferation. Genes Dev (2000) 3.26
The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J (1991) 3.15
Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol (1985) 3.09
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell (1989) 3.08
Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol (1988) 3.02
The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene (1993) 2.99
The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell (1989) 2.98
Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol (1992) 2.97
Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature (1983) 2.96
Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell (2000) 2.95
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev (2000) 2.90
E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev (1994) 2.86
The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J (1990) 2.80
Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol (1999) 2.79
Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature (1991) 2.78
Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev (1996) 2.71
The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc Natl Acad Sci U S A (2001) 2.65
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature (1997) 2.60
p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev (1995) 2.60
Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells. J Virol (1981) 2.60
Structural organization and expression of the mouse estrogen receptor. Mol Endocrinol (1987) 2.54
Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat Genet (1998) 2.53
pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A (1998) 2.49
Nuclear organization of DNA replication in primary mammalian cells. Genes Dev (2000) 2.48
Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med (1986) 2.44
Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol (1987) 2.42
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol (1990) 2.40
Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (1992) 2.39
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev (1995) 2.33
E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol (1997) 2.33
Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv (1992) 2.29
Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production. J Virol (1986) 2.27
Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol (2000) 2.27
Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev (1996) 2.26
E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol (1995) 2.26
E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol Cell (2000) 2.21
Physical mapping of the globin gene deletion in hereditary persistence of foetal haemoglobin (HPFH). Nucleic Acids Res (1980) 2.20
Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene (1993) 2.20
Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol Cell Biol (1991) 2.20
E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev (2001) 2.16
Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev (1998) 2.14
RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol Cell Biol (2001) 2.14
Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13
Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc Natl Acad Sci U S A (1999) 2.10
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development (1993) 2.09
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol (2000) 2.05
Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell (1998) 2.02
TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. Proc Natl Acad Sci U S A (1993) 2.00
In vivo association of E2F and DP family proteins. Mol Cell Biol (1995) 1.99
E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc Natl Acad Sci U S A (1998) 1.99
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev (1998) 1.97